Tocilizumab for steroid refractory acute graft-versus-host disease

Acute graft-versus-host-disease (aGVHD) is a frequent and often lethal complication of allogeneic hematopoietic stem cell transplant despite prophylaxis. Tocilizumab is a humanized anti-IL-6 receptor monoclonal antibody that has evidence of activity in patients with steroid refractory (SR) GVHD. We...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Leuk Lymphoma
Autores principales: Roddy, Julianna V. F., Haverkos, Bradley M., McBride, Ali, Leininger, Kathryn M., Jaglowski, Samantha, Penza, Sam, Klisovic, Rebecca, Blum, William, Vasu, Sumithira, Hofmeister, Craig C., Benson, Don M., Andritsos, Leslie A., Devine, Steven M., Efebera, Yvonne A.
Formato: Artigo
Lenguaje:Inglês
Publicado: 2015
Materias:
Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC4698359/
https://ncbi.nlm.nih.gov/pubmed/26140610
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3109/10428194.2015.1045896
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares